Callan Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,000	Closed	-$209K	–	63
2015 Q2	$209K	Sell	5,000 -5,000	-50%	-$209K	0.04%	64
2015 Q1	$326K	Hold	10,000	–	–	0.07%	56
2014 Q4	$318K	Hold	10,000	–	–	0.07%	61
2014 Q3	$248K	Buy	+10,000	New	+$248K	0.07%	60